论文部分内容阅读
目的:观察参附注射液对脑梗死急性期(元气虚衰证)血浆D-二聚体及CRP的影响。方法:60例随机分为治疗组30例及对照组30例。两组均用常规西医疗法,治疗组加用参附注射液静脉滴注。结果:两组血浆D-二聚体、CRP及神经功能缺损程度评分均有改善,治疗组疗效优于对照组(P<0.05)。用药期间无不良反应。结论:参附注射液治疗脑梗死急性期(元气虚衰证),能降低血浆D-二聚体及CRP,提高临床疗效。
Objective: To observe the effect of Shenfu injection on plasma D-dimer and CRP in acute cerebral infarction (Yuan-Qi Deficiency Syndrome). Methods: 60 cases were randomly divided into treatment group 30 cases and control group 30 cases. Both groups were treated with conventional Western medicine, the treatment group plus Shenfu injection intravenous drip. Results: The scores of plasma D-dimer, CRP and neurological deficit in both groups were improved, and the curative effect in the treatment group was better than that in the control group (P <0.05). No adverse reactions during treatment. Conclusion: Shenfu injection in the treatment of acute cerebral infarction (Yuan Qi deficiency decoction), can reduce plasma D-dimer and CRP, improve clinical efficacy.